A previous study demonstrated that dysregulated ZIP7 modulates TPI1 expression in skeletal muscle cells and is involved in cardiovascular diseases, AD, and diabetes (Myers et al., 2013). This evidence concerns the gene SLC39A7 and Alzheimer disease.